View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 21-May-2024 / 14:00 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

TELA Bio Appoints Greg Firestone as Chief Commercial Officer MALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer. In this role, Mr. Firestone will oversee the Company’s commercial operations, including key product launches, sales team training, market development, as well as strategic initiatives to optimize market access and reimbursement strategy across...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 20-May-2024 / 15:01 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

Embassy Bancorp, Inc. Announces Results of Operations as of and for th...

Embassy Bancorp, Inc. Announces Results of Operations as of and for the Three Months ended March 31, 2024 BETHLEHEM, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company”) has filed its Form 10-Q on May 15, 2024, a copy of which can be found at . Highlights of the filing, which includes consolidated financial information of the Company and Embassy Bank For the Lehigh Valley (the “Bank”), the Company’s wholly-owned subsidiary, include: Loans receivable increased to $1.271 billion at March 31, 2024, an increase of $17.5 million, from $1.254 billion at De...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 16-May-2024 / 14:24 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 15-May-2024 / 14:05 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 13-May-2024 / 14:32 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

Galera Reports First Quarter 2024 Financial Results and Recent Corpora...

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates Company’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced financial results for the first quarter ended March 31, 2024, and provided recent corporate updates. "Our review of strategic ...

 PRESS RELEASE

CECO Environmental Announces Upcoming Investor Conferences

CECO Environmental Announces Upcoming Investor Conferences DALLAS, May 13, 2024 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announces that Todd Gleason, Chief Executive Officer, and Peter Johansson, Chief Financial and Strategy Officer, will present at the following investor conferences: May 23, 2024 – TD Cowen 2nd Annual Sustainability Week.May 29, 2024 – The 21st Annual Craig-Hallum Institutional Investor Conference in Minne...

 PRESS RELEASE

Parsons Celebrates 80 Years of Infrastructure Excellence

Parsons Celebrates 80 Years of Infrastructure Excellence CHANTILLY, Va., May 13, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) today celebrates Infrastructure Week, an annual event focused on raising awareness of the importance of infrastructure. As a critical element of the economy, infrastructure plays a vital role in connecting people, communities, and businesses around the world. “Our dedicated professionals have designed and delivered the global infrastructure that connects and protects communities around the world for 80 years,” said Mark Fialkowski, president, Infrastru...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: May 11, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024 (the "Grant Date"). The restricted stock units were granted pursua...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 10-May-2024 / 15:06 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

TELA Bio Reports First Quarter 2024 Financial Results

TELA Bio Reports First Quarter 2024 Financial Results MALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the first quarter ended March 31, 2024. Recent Highlights Reported revenue of $16.6 million in the first quarter, representing growth of 39% over the prior year period of 2023;Delivered the 13th consecutive quarter of at least 35% year-over-year growth;Increased demand for OviTex® and OviTex PRS Reinforced Tis...

 PRESS RELEASE

Farmer Brothers reports third quarter fiscal 2024 financial results an...

Farmer Brothers reports third quarter fiscal 2024 financial results and publishes quarterly shareholder letter Fiscal Q3 2024 net sales of $85.4 million Gross margin increase of 660 basis points year-over-year to 40.1% NORTHLAKE, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Farmer Bros. Co. (NASDAQ: FARM) today reported its third quarter fiscal 2024 financial results for the period ended March 31, 2024. The company filed its Form 10-Q and published its quarterly shareholder letter, which contains additional details regarding the results. Both of those documents can be found on the section o...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporat...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation 09-May-2024 / 14:03 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a tr...

 PRESS RELEASE

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results an...

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Completed SNS-101 monotherapy and combination dose escalation through 15mg/kg with no dose limiting toxicities - - Company to present topline clinical data from the SNS-101 Phase 1 dose escalation study at the 2024 ASCO Annual Meeting - - Enrollment in the dose expansion portion of the clinical study advancing - - Strong balance sheet with cash runway into fourth quarter of 2025 - BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage imm...

 PRESS RELEASE

Parsons To Design Advanced Rapid Transit System in San Antonio

Parsons To Design Advanced Rapid Transit System in San Antonio CHANTILLY, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that the company was selected by VIA Metropolitan Transit Authority (VIA) to complete final design of the Advanced Rapid Transit (ART) program for the VIA Rapid Green Line in San Antonio, Texas. The $20 million, five-year contract represents new work for the company. “San Antonio’s ART program is an innovative approach to improving community connectivity,” said Sean Tenney, vice president and Texas Regional Manager for Parsons. “T...

 PRESS RELEASE

Lesaka Q3 2024 Results: Lesaka continues to deliver improved profitabi...

Lesaka Q3 2024 Results: Lesaka continues to deliver improved profitability JOHANNESBURG, South Africa, May 08, 2024 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the third quarter ended March 31, 2024 (“Q3 2024”). Performance Highlights for Q3 2024: Revenue of $138.2 million (ZAR 2.6 billion)1 in Q3 2024, compared to $134.0 million (ZAR 2.4 billion)1 for the third quarter ended March 31, 2023 (“Q3 2023”), an increase of 9% in South African Rand (“ZAR”).Operating income of $0.8 million (ZAR 15.0 million) for the quarter, compared to an ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch